Meihua International Medical Technologies Co., Ltd.’s EV / EBITDA at a glance
Meihua International Medical Technologies Co., Ltd. reports ev / ebitda of 0.1x for Dec 2024. The prior period recorded 1.6x (Dec 2023). Year over year the metric moved −1.55 (−94.4%). The rolling three-period average stands at 5.6x. Data last refreshed Nov 20, 2025, 4:19 PM.
Latest reading
0.1x · Dec 2024
YoY movement
−1.55 (−94.4%)
Rolling average
5.6x
Current EV / EBITDA
0.1x
−1.55
−94.4%
Rolling average
5.6x
Latest Value
0.1x
Dec 2024
YoY Change
−1.55
Absolute
YoY Change %
−94.4%
Rate of change
3-Period Avg
5.6x
Smoothed
Narrative signal
Meihua International Medical Technologies Co., Ltd.’s ev / ebitda stands at 0.1x for Dec 2024. Year-over-year, the metric shifted by −1.55, translating into a −94.4% rate of change versus the prior period.
Pair this momentum with product cadence, pricing power, and capital allocation moves to understand durability.
Blend with balance sheet, cash flow, and peer benchmarks from AlphaPilot’s broader dashboards to shape an investable thesis.
How ev / ebitda shapes Meihua International Medical Technologies Co., Ltd.'s story
As of Dec 2024, Meihua International Medical Technologies Co., Ltd. reports ev / ebitda of 0.1x. Use EV/EBITDA to benchmark acquisition multiples, leverage-adjusted valuation, and comparable transaction ranges.
Why EV/EBITDA matters
It normalizes valuation across different leverage levels, making it a go-to metric for M&A and cross-company comparisons.
Watch for cyclical swings
EBITDA can swing with cycle-sensitive businesses. Track multi-year averages and peak vs. trough to understand value ranges.
Valuation Multiples
Compare how the market prices revenue, equity, and operating cash flow versus peers and history.
Profitability & Margins
Understand cost structure and capital efficiency trends across gross, operating, and net results.
Gross Margin
34.4%
Operating Margin
14.8%
Net Profit Margin
11.2%
Return on Equity
6.8%
Return on Assets
5.8%
Growth Momentum
Track whether top-line, earnings, and free cash flow growth are accelerating or cooling.
Balance Sheet Strength
Evaluate leverage, liquidity, and cash generation capacity that underpin resilience.
Shareholder Returns
Follow dividend sustainability and cash generation relative to market value.
Meihua International Medical Technologies Co., Ltd. (MHUA) FAQs
Answers tailored to Meihua International Medical Technologies Co., Ltd.’s ev / ebitda profile using the latest Financial Modeling Prep data.
What is Meihua International Medical Technologies Co., Ltd.'s current ev / ebitda?
As of Dec 2024, Meihua International Medical Technologies Co., Ltd. reports ev / ebitda of 0.1x. This reading reflects the latest filings and price data for MHUA.
How is Meihua International Medical Technologies Co., Ltd.'s ev / ebitda trending year over year?
Year-over-year, the figure shifts by −1.55 (−94.4%). Pair this context with revenue growth and free cash flow signals to gauge momentum for MHUA.
Why does ev / ebitda matter for Meihua International Medical Technologies Co., Ltd.?
The enterprise value to EBITDA ratio evaluates valuation relative to operating cash flow before capital structure impacts. For Meihua International Medical Technologies Co., Ltd., operating within Healthcare — Medical - Instruments & Supplies, tracking this metric helps benchmark management's execution against close competitors.
Is Meihua International Medical Technologies Co., Ltd.'s ev / ebitda above its recent average?
Meihua International Medical Technologies Co., Ltd.'s rolling three-period average sits at 5.6x. Comparing the latest reading of 0.1x to that baseline highlights whether momentum is building or fading for MHUA.
How frequently is Meihua International Medical Technologies Co., Ltd.'s ev / ebitda refreshed?
Data for MHUA was last refreshed on Nov 20, 2025, 4:19 PM and updates automatically every 24 hours, keeping your valuation inputs current.